fda bpc-157 not approved for human use warning letter issued 25 letters to telehealth companies false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have been proven to be safe, effective, or of FDA Issues Warning Letters Against
Description
Most therapeutic peptides require subcutaneous or intravenous administration
Researchers may unknowingly lose a measurable amount of peptide before beginning an experiment
The grey market problem Heres what access actually looks like right now
Without treatment, vitamin B12 deficiency can cause physical, neurological and psychological problems
